RAF1 and cardiofaciocutaneous syndrome: Currently, all known mutations linked to CFC syndrome act in the RAS-RAF-MEK pathway to enhance ERK signaling (Aoki et al., 2008; Simanshu et al., 2017; Bustelo et al., 2018; Dard et al., 2018).